3004.31.00.00/NovoLog FlexPen Insulin/Japan

NovoLog FlexPen Insulin from Japan

NovoLog FlexPen contains rapid-acting insulin aspart for mealtime blood glucose control in diabetic patients. The pre-filled 3mL pen (100 units/mL) provides dialable measured doses suitable for retail sale. HTS 3004.31.00.00 applies to this insulin-containing medicament in therapeutic dose form.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• EU/US insulin imports often qualify for zero duty under pharmaceutical appendices or FTAs—verify HS preferences

• Include GMP certificates and stability data; FDA may require comparative dissolution profiles for biosimilars